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TRANSLATIONAL SCIENCES
18F-Sodium Fluoride Positron Emission Tomography/
Computed Tomography in Ex Vivo Human 
Coronary Arteries With Histological Correlation
Trisha Youn, Subhi J. Al’Aref, Navneet Narula, Steven Salvatore, David Pisapia, Marc R. Dweck, Jagat Narula, Fay Y. Lin,  
Yao Lu, Amit Kumar, Renu Virmani, James K. Min
OBJECTIVE: 18F-sodium fluoride (NaF) position emission tomography (PET) activity correlates with high-risk plaque. We examined the 
correlation between 18F-NaF PET activity and extent of calcification (microcalcification and macrocalcification) in coronary arteries.
APPROACH AND RESULTS: Eighteen ex vivo human coronary arteries were imaged with 18F-NaF PET/CT, and target to background 
ratios were analyzed from 101 plaques. Histopathologic analysis evaluated for microcalcification and macrocalcification, 
plaque morphology, and inflammation. Plaques with microcalcification demonstrated higher 18F-NaF PET activity (n=84; 
mean target to background ratio±SD, 9.0±9.7,) than plaques without microcalcification (n=17, 2.9±3.8; P<0.0001). Higher 
18F-NaF PET activity was associated with advanced plaques characterized by fibroatheroma (n=54, 10.7±10.3) compared 
with plaques with intimal thickening (n=22, 3.5±3.9) or pathological intimal thickening (n=25, 6.1±8.4; P=0.004). No 
significant association was found between 18F-NaF PET activity and inflammation (P=0.08).
CONCLUSIONS: In ex vivo human coronary arteries, higher 18F-NaF PET activity was associated with microcalcification and 
advanced plaque morphology. Since microcalcification and fibroatheromas are high-risk plaque features, 18F-NaF PET/CT 
may improve risk-stratification.
VISUAL OVERVIEW: An online visual overview is available for this article.
Key Words: atherosclerotic plaque ◼ calcification ◼ computed tomography angiography ◼ inflammation ◼ risk factor
Prediction of future adverse events in coronary heart disease remains challenging.1 Identification of high-risk plaque precursors for myocardial infarction is 
one potential strategy for individualized assessment of 
cardiovascular risk. Characteristics of high-risk plaque 
on noninvasive imaging, such as computed tomography 
(CT) angiography, include the presence of low attenua-
tion plaque, positive arterial remodeling, and microcalcifi-
cation.2,3 Also, while the presence of macrocalcification is 
generally associated with healed and stable plaque, the 
presence of microcalcification is, by contrast, a hallmark 
of unstable plaque.4 Macrocalcification can be readily 
detected by conventional CT imaging, while the presence 
of microcalcification can be challenging to assess due to 
spatial resolution constraints.5,6
18F-sodium fluoride (NaF) is a radiotracer that prefer-
entially identifies microcalcification in arteries by binding 
to hydroxyapatite.4,7–9 18F-NaF positron emission tomogra-
phy (PET) activity also co-localizes to high-risk and culprit 
coronary plaque and is currently being investigated as a 
prognostic marker in the large multicenter PREFFIR study 
(Prediction of Recurrent Events With 18F-Fluoride). Stud-
ies have been performed in carotid artery specimens cor-
relating 18F-NaF activity with microcalcification.10 However, 
within the coronary arteries, the histopathologic correlation 
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macrophage activity, and plaque morphology with 18F-NaF 
PET activity remains relatively unknown. This study aimed at 
investigating the correlates of 18F-NaF PET activity against 
the histopathologic gold standard in ex vivo human coronary 
arteries. We hypothesize that 18F-NaF PET activity would 
identify high-risk plaque via detection of microcalcification 
with and without the presence of lower-risk macrocalcifica-
tion, advanced plaque morphology, and macrophage burden.
MATERIALS AND METHODS
The authors declare that all supporting data are available within 
the article.
Specimen Selection
In this prospective cross-sectional study, we performed 18F-NaF 
PET/CT on ex vivo coronary arteries from 9 deidentified patients 
who had undergone autopsy at Weill Cornell Medicine between 
2015 and 2016. There were no prespecified exclusion crite-
ria. This study was exempt from review by the local Institutional 
Review Board as it involved autopsy material, and no identifying 
information including clinical history was collected.
Two coronary artery samples were obtained per patient with the 
left main, left anterior descending, and left circumflex arteries as one 
specimen and the right coronary artery as the second specimen. 
Coronary artery specimens were obtained at the time of autopsy 
and placed in 4% formalin. A total of 18 coronary arteries were col-
lected and imaged with 18F-NaF PET/CT (Figure 1). One coronary 
artery was excluded due to technical difficulty in identifying which 
segments to slice by the pathologist as the coronary artery speci-
men changed in gross morphology after the PET/CT scan.
A total of 191 plaques from 17 coronary arteries were 
selected of which 90 plaques were subsequently excluded due 
to contamination of slides with calcified particles during the 
slicing process. A total of 101 coregistered plaques underwent 
histological analysis. Twenty-seven plaques were stained with 
hematoxylin and eosin Y (H&E), Von Kossa (VK), and CD68. 
Forty-three plaques were stained with H&E and VK, and 31 
plaques were stained with H&E and CD68 without VK due 
to decalcification of the specimen during sample preparation. 
Slides prepared with EXAKT technology left an inadequate 
amount of tissue for staining with CD68.
Ex Vivo PET/CT Imaging
Coronary samples were immersed in 18F-NaF (NCM USA, NY) 
solution diluted with PBS to a total activity of 0.37 MBq/mL 
(Life Technologies; Carlsbad, CA). After 60 minutes, coronary 
artery specimens were rinsed 3× in PBS before being placed 
into either a micro or clinical PET/CT scanner. The choice of 
scanner depended on availability.
A small animal micro-PET/CT system (Inveon, Siemens 
Medical Solutions) was used for imaging 14 coronary arteries. 
PET scan parameters were as follows: 5 minute acquisition/
bed position, total 2 bed positions, 16 detector blocks (20×20 
array of 1.5×1.5×10 mm lutetium oxyorthosciilicate crys-
tal), total of 64 detectors, 12.7 cm axial and 10 cm transaxial 
field of view, and 3 dimensional OSEM-MAP (ordered subsets 
expectation maximization-maximum a posteriori) reconstruc-
tion algorithm. CT scan parameters were as follows: 165 mm, 
10×10 cm (4064×4064 pixels) field of view, 80 kVP, 0.5 mA, 
and 196 µm resolution.
An integrated clinical PET/CT system (Biograph TruePoint 
PET/CT, Siemens Medical Solutions) was used to image 4 cor-
onary arteries. PET scan parameters were as follows: 20 min-
ute acquisition/bed position, total 1 bed position, 3D mode, 3 
rings of 48 detectors blocks, 13×13 lutetium oxyorthosciilicate 
crystals (4×4×20 mm), 4 photomultiplier tubes, 163 mm field 
of view, 2 mm slice thickness, and 3D OSEM reconstruction 
algorithm. CT scan parameters were as follows: 16-slice helical 
CT (Somatom Sensation 16; Siemens Medical Solutions), 78 
cm aperture, 2 mm slice thickness, minimum rotation time 0.3 
seconds per 360°, maximum scan time per spiral 80 seconds, 
140 kVP, 20 to 800 mA, and 0.24 mm reconstructed spatial 
resolution.
Image/Pathology Interpretation and Data 
Analysis
PET and CT scans were analyzed by an experienced nuclear 
medicine radiologist (T. Youn). Images were read and analyzed 
using advanced PET/CT review software (Inveon Research 
Workplace 4.2, Siemens Medical Solutions), which allowed 
analysis of PET, CT and fusion images in transverse, coronal, 
and sagittal planes with 3D visualization.
Regions of interest were selected if the arterial segment 
exhibited (1) focally increased 18F-NaF activity with calcification 
on CT (PET+/CT+), (2) focally increased 18F-NaF activity without 
calcification on CT (PET+/CT−), (3) no significant 18F-NaF activ-
ity with calcification on CT or (PET−/CT+), and (4) no significant 
Nonstandard Abbreviations and Acronyms
H&E hematoxylin and eosin Y
TBR target to background ratio
VK Von Kossa
Highlights
• This study was performed to determine the correla-
tion between 18F-NaF activity and microcalcification 
in human coronary arteries.
• The current investigation demonstrated that high 
18F-NaF activity was associated with microcalcifica-
tion in the coronary arteries, a feature of vulnerable 
plaque.
• High 18F-NaF activity was also noted in the pres-
ence of advanced plaque morphology characterized 
by fibroatheromas, a feature of vulnerable plaque.
• Lower 18F-NaF activity was associated with plaque 
without microcalcification or only macrocalcification 
and early plaque morphology characterized by 
intimal thickening.
• 18F-NaF PET/CT of the coronary arteries has the 



















Youn et al 18F-NaF PET/CT in Coronary Arteries With Histology
406  February 2020 Arterioscler Thromb Vasc Biol. 2020;40:404–411. DOI: 10.1161/ATVBAHA.119.312737
18F-NaF activity or calcification on CT (PET−/CT−). Increased 
18F-NaF activity was defined as visually assessed activity above 
background. No significant 18F-NaF activity was defined as visu-
ally assessed activity similar to or below background. Regions 
of interest were drawn using transverse, coronal, sagittal, and 
3D PET images for anatomic guidance. 18F-NaF PET activity for 
each arterial segment was quantified using the target to back-
ground ratio (TBR) which was generated as follows: maximum 
counts on 18F-NaF PET images in the region of interest divided 
by the maximum counts on 18F-NaF PET images in the region of 
interest without significant 18F-NaF activity or calcification on CT.
Histology/Immunohistochemistry and Data 
Analysis
After PET scanning, coronary artery specimens were sec-
tioned based on coregistration with regions of interest chosen 
with 18F-NaF PET/CT imaging. Radiographs were performed 
for further guidance if necessary. Severely calcified coronary 
specimens were processed based on a protocol at the CVpath 
institute using the EXAKT cutting and grinding system (EXAKT 
Technologies, Inc). Specimens were embedded in methylmeth-
acrylate after dehydration in graded series of alcohol, sawed at 
4 mm intervals, ground by EXAKT method between 70 and 120 
microns, and stained with toluidine blue. Arteries with moder-
ate calcification were decalcified in EDTA, whereas those with 
mild calcification were directly, without decalcification sectioned 
between 4 and 6 microns. Slides were subsequently stained 
with H&E and VK to detect calcification. They also underwent 
immunohistochemical staining for CD68 expression (mouse 
anti-human CD68 mAb, M0876, Dako) on a Leica Bond sys-
tem using the standard protocol F. The section was pretreated 
using heat mediated antigen retrieval with sodium citrate buffer 
(pH 6, epitope retrieval solution 1) for 30 minutes. The section 
was then incubated with Agilent antibody (Catalog: M081401-
2, 1:4000 dilution) for 15 minutes at room temperature and 
detected using a horseradish peroxidase conjugated compact 
polymer system. DAB (3,3′-diaminobenzidine) was used as the 
chromogen. The section was then counterstained with hema-
toxylin and mounted with Leica Micromount.
Histological slides were analyzed by an experienced pathol-
ogist (N. Narula). Microcalcification was defined as 0.5 to 15 
µm in diameter, and macrocalcification was defined as calcifi-
cation >15 µm in diameter. Calcification was evaluated on sec-
tions stained with H&E and VK. The primary outcome was the 
binary presence or absence of microcalcification on histopa-
thology. Plaques with microcalcification included plaques with 
only microcalcification as well as plaques with both microcalci-
fication and macrocalcification. Plaques without microcalcifica-
tion included plaques with only macrocalcification and plaques 
without calcification. Atherosclerotic plaques were classified 
according to the modified American Heart Association clas-
sification into adaptive intimal thickening, pathological intimal 
thickening and fibroatheroma, as evaluated with H&E stained 
sections. The number of macrophages as assessed by immu-
nohistochemical stain for CD68 were graded as follows: grade 
0: a group comprising ≤5 cells; grade 1: a group between 6 
and 50 cells or >1 group of <5 cells; grade 2: 2 to 5 groups 
of 6 to 50 cells; and grade 3: >5 groups of <50 cells or >1 
group of >50 cells.11
Figure 1. Flow diagram depicting the study design. 
A total of 101 coregistered plaques underwent histological analysis. Twenty-seven plaques were stained with hematoxylin and eosin Y (H&E), 
Von Kossa (VK), and CD68. Forty-three plaques were stained with H&E and VK without CD68 due to scarcity of tissue, and 31 plaques were 
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Statistical Analysis
18F-NaF activity quantified by mean TBR was compared across 
groups. Larger mean TBR represented higher 18F-NaF activity. 
The ANOVA test was used to compare plaques with different 
calcification, plaque morphology, and CD68 staining. The Tukey 
Honest Significance test was used to compare any 2 CD68 
subgroups. The generalized estimating equation with adjustment 
of patient-level effect was performed on the log-transformed 
mean TBR, and exchangeable correlation structure was used in 
generalized estimating equation modeling. A 2-sided P value of 
<0.05 was considered statistically significant. Statistical analy-
sis was performed using R (version 3.5.2 [2018-12-20]) and 
Stata 14 (StataCorp LP. College Station, TX).
RESULTS
Comparison of 18F-NaF Activity in Plaques With 
and Without Microcalcification
We evaluated 101 plaques in 17 coronary arteries from 9 
patients (Table and Figures 2 and 3). Eighty-four (83.2%) 
plaques demonstrated microcalcification and included 43 
(42.6%) plaques with both microcalcification and macrocalci-
fication and 41 (40.6%) plaques with only microcalcification. 
Seventeen (16.8%) plaques did not demonstrate microcalci-
fication and included 2 (2.0%) plaques with only macrocalci-
fication and 15 (14.9%) plaques without calcification.
Plaques with microcalcification demonstrated higher 
18F-NaF activity (mean TBR±SD, 9.0±9.7) than plaques 
without microcalcification (mean TBR±SD, 2.9±3.8; 
P<0.0001). Regression analysis found plaques with 
microcalcification demonstrated 2.8× higher mean 
TBR (95% CI, 2.4–3.4; P<0.0001) than plaques with-
out microcalcification.
Comparison of 18F-NaF Activity Between 
Plaques With Different Types of Calcification
A significant difference in mean TBR was found between 
plaques without calcification (mean TBR±SD, 3.1±4,1), 
only microcalcification (mean TBR±SD, 6.9±9.5), both 
microcalcification and macrocalcification (mean TBR±SD, 
11.1±9.6) and only macrocalcification (mean TBR±SD, 
1.8±0.4, P=0.01) using ANOVA (Table and Figure 3). 
Plaques with only microcalcification demonstrated 2.0× 
higher mean TBR than plaques without calcification (95% 
CI, 1.7–2.3; P<0.0001). Plaques with both microcalcifi-
cation and macrocalcification demonstrated 2.7× higher 
mean TBR than plaques with only macrocalcification 
(95% CI, 1.8–3.9; P<0.001). Using generalized estimating 
equation, no significant difference in 18F-NaF activity was 
found between plaques without calcification and plaques 
with only macrocalcification (P=0.9). Additionally, no sig-
nificant difference in 18F-NaF activity was found between 
plaques with both microcalcification and macrocalcifica-
tion and plaques with only microcalcification (P=0.9).
Comparison of 18F-NaF Activity in Plaques With 
Different Plaque Morphology
Plaque morphology, from early to more advanced 
stages, was classified as fibroatheroma in 54 plaques 
(53.5%), pathological intimal thickening in 25 plaques 
(24.8%), and intimal thickening in 22 plaques (21.8%; 
Table and Figure 3).
Coronary fibroatheromas demonstrated higher 18F-
NaF activity (mean TBR±SD, 10.7±10.3) compared with 
plaques with less advanced plaque morphology, including 
intimal thickening (mean TBR±SD, 3.5±3.9) and patholog-
ical intimal thickening (mean TBR±SD, 6.1±8.4; P=0.004).
Comparison of 18F-NaF Activity in Plaques With 
Different Degrees of CD68 Staining
CD68 staining, a marker of macrophages and inflamma-
tory burden, was classified grade 0 in 22 plaques (37.9%), 
grade 1 in 7 plaques (12.1%), grade 2 in 7 plaques 
(12.1%), and grade 3 in 22 plaques (37.9%; Table).
Although not statistically significant (P=0.08), plaques 
with higher degrees of CD68 staining generally demon-
strated higher 18F-NaF activity compared with plaques with 
lower degrees of CD68 staining. Plaques with grade 3 
CD68 staining had higher 18F-NaF activity (mean TBR±SD, 
Table. 18F-Sodium Fluoride Positron Emission Tomography 
Activity in Plaques Categorized by the Presence of Micro-
calcification, Subgroups of Calcification, Plaque Grade, and 






 Microcalcification 9.0 (9.7) 84 <0.0001*†
 No microcalcification 2.9 (3.8) 17
Subgroups of calcification
 No calcification 3.1 (4.1) 15 0.01*†
 Only microcalcification 6.9 (9.5) 41
 Microcalcification/macrocalcification 11.1 (9.6) 43
 Only macrocalcification 1.8 (0.4) 2
Plaque grade
 Fibroatheroma 10.7 (10.3) 54 0.004*†
 Pathological intimal thickening 6.1 (8.4) 25
 Intimal thickening 3.5 (3.9) 22
Grade of CD68 staining
 Grade 0 CD68 staining 3.2 (3.4) 22 0.08*†
 Grade 1 CD68 staining 4.8 (5.6) 7
 Grade 2 CD68 staining 4.9 (3.7) 7
 Grade 3 CD68 staining 10.4 (14.1) 22
 Missing staining from lack of tissue 10.3 (8.3) 43
TBR indicates target to background ratio.
*ANOVA test.
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10.4±14.1) compared with plaques with grade 0 CD68 
staining (mean TBR±SD, 3.2±3.4), plaques with grade 1 
CD68 staining (mean TBR±SD, 4.8±5.6), and plaques with 
grade 2 CD68 staining (mean TBR±SD, 4.9±3.7). Plaques 
in which CD68 staining could not be performed due to lack 
of tissue as noted in the methods section, demonstrated 
high 18F-NaF activity (mean TBR±SD, 10.3±8.3). No sig-
nificance was found in adjusted P values comparing any 2 
CD68 subgroups. Statistical comparisons of the associa-
tion between TBR and grades of CD68 staining may have 
been underpowered due to the small sample size.
DISCUSSION
In this study, we demonstrated in ex vivo human coronary 
artery plaques that higher 18F-NaF activity is observed 
in plaques with microcalcification compared with those 
without microcalcification. 18F-NaF detects calcification 
by irreversibly binding to hydroxyapatite in calcification.7 
Electron microscopy has demonstrated colocalization of 
fluoride to arterial calcification.4 Given that microcalcifi-
cation is a marker of high-risk coronary plaque, cannot 
be detected by conventional CT4,6 and is masked on CT 
imaging by the presence of macrocalcification, 18F-NaF 
PET/CT could be a useful noninvasive method to detect 
vulnerable plaque.
The current investigation demonstrated that higher 
18F-NaF activity was associated with features of vulner-
able plaque including the presence of microcalcification, 
either with or without macrocalcification and advanced 
plaque morphology characterized by fibroatheromas 
(Figure 3). Similar to findings from carotid artery speci-
men examined by Irkle et al,4 we also did not find an 
association with inflammation and 18F-NaF activity in 
the coronary arteries. However, this may be due to the 
small sample size. Lower 18F-NaF activity was associ-
ated with the lack of calcification or only macrocalci-
fication and early plaque morphology characterized by 
intimal thickening (Figure 3). Plaques in which CD68 
staining could not be performed due to difficulty sec-
tioning heavy calcification, demonstrated high 18F-
NaF activity. There is a possibility that these excluded 
samples contained arterial segments with both micro-
calcification and macrocalcification, hence demonstrat-
ing high 18F-NaF activity. However, further studies are 
needed to evaluate this hypothesis.
This study demonstrates correlation of 18F-NaF PET/
CT imaging with histology in the coronary arteries. In 
the carotid arteries, prior studies demonstrated 18F-NaF 
PET activity co-localized with calcification on CT and 
ruptured plaque.12,13 18F-NaF PET activity was also found 
to have a positive correlation with markers of active cal-
cification, macrophage infiltration, apoptosis, and necro-
sis seen in endarterectomy specimen.12 18F-NaF activity 
correlated with intravascular ultrasound findings of high-
risk plaque, which include spotty calcification, positive 
remodeling, and necrotic core.12 Furthermore, 18F-NaF 
activity was highest in angiographically determined cul-
prit lesions compared with nonculprit lesions.12 Finally, 
18F-NaF activity in the coronary arteries correlated with 
prevalent cardiovascular risk factors such as older age, 
male sex, higher coronary calcium scores, and Framing-
ham risk scores.8
Coronary heart disease is a major cause of morbidity 
and mortality worldwide and is prevalent in both males 
and females.14 Current clinical practice has focused on 
the development of risk scores and predictive models 
that would risk-stratify individuals, with the hope of 
preventing adverse cardiovascular events in the high-
est risk group, albeit with limited accuracy. Noninvasive 
imaging, which uses computed tomography, has been 
geared towards coronary luminal evaluation and char-
acterization of atherosclerotic plaque. Although CT can 
provide information on the presence of high-risk plaque 
features, the ability to predict culprit lesions in incident 
acute coronary events is limited. Molecular coronary 
Figure 2. Higher 18F-sodium fluoride 
(NaF) positron emission tomography 
(PET) activity is seen in plaque with 
microcalcification (mean target to 
background ratio [TBR]±SD, 9.0±9.7) 
compared with plaque without 
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imaging has been touted as the future of atheroscle-
rosis evaluation and prognostication. Although correlat-
ing to macrophage infiltration in the carotid arteries,15 
18F-fluorodeoxyglucose PET/CT has a limited role 
for the evaluation of high-risk plaque in the coronary 
arteries due to adjacent physiological activity in the 
Figure 3. Chart demonstrating 18F-sodium fluoride (NaF) positron emission tomography (PET) image, CT image, fused 18F-NaF PET/
CT image, and histology of plaques without calcification, only microcalcification or both microcalcification and macrocalcification. 
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myocardium.8,12,16 However, our study indicates that there 
is potential for improvement in risk-stratification of indi-
vidual plaque with 18F-NaF PET/CT imaging which is not 
hindered by physiological activity within the myocardium.
This study also demonstrates that microcalcification 
and high 18F-NaF activity likely indicates an active calci-
fication process while macrocalcification and low 18F-NaF 
activity may indicate advanced calcification and healed 
plaque. Microcalcification, measuring 0.5 to 15 µm in diam-
eter, results from the formation of hydroxyapatite crystals 
after apoptosis of smooth muscle cells, or may result from 
matrix vesicles released by macrophages. Intimal micro-
calcification has been associated with high-risk plaque.2,17 
This idea that microcalcification is an active process, and 
macrocalcification is a healed stage was supported in ear-
lier studies. 18F-NaF activity was seen in areas of the cor-
onaries without CT and intravascular ultrasound verified 
calcification, and 18F-NaF activity was also seen in areas 
of the aortic valve without calcification that later developed 
macrocalcification on CT.8,18 Presumably in these studies, 
the areas 18F-NaF activity without calcification likely had 
microcalcification which healed and led to macrocalcifica-
tion. On electron microprobe analysis, increased fluoride 
was seen in microcalcification compared with macrocalci-
fication. In carotid arteries, 18F-NaF activity localized to the 
surface of macrocalcification, as 18F-NaF could not pene-
trate its core, leading to lower activity in plaques with mac-
rocalcification than with plaques with microcalcification.4 
18F-NaF activity has been found to correlate with hydroxy-
apatite expression, which is likely higher in concentration 
within microcalcification compared with within macrocalci-
fication, and not to overall extent of calcification.19
Furthermore, 18F-NaF activity was not elevated in 
41% of patients with coronary calcium scores >10008, 
indicating the presence of macrocalcification. Previously, 
18F-NaF activity inversely correlated with calcium den-
sity in coronary lesions in individuals with malignancies, 
where 18F-NaF activity was highest in plaques without CT 
evidence of calcification or low CT density.20
Limitations of the Study
There were several limitations to the study. First, it was 
technically challenging to section selected plaques using 
18F-NaF imaging as guidance. As a result, one coro-
nary artery and 90 plaques were excluded from analysis 
due to difficulties with correlation to the 18F-NaF PET/
CT images. Furthermore, relatively few plaques without 
significant 18F-NaF activity were selected for evaluation, 
and as a result the investigation only included 2 plaques 
with macrocalcification for analysis. Second, heavily cal-
cified arteries were difficult to section. During sectioning, 
many plaques were contaminated with calcified particles 
resulting in exclusion from analysis. Additionally, fre-
quently there was an inadequate amount of tissue for 
staining with CD68. Decalcification of segments also 
left an inadequate amount of calcium for staining with 
VK. Given that the specimen were obtained from ran-
dom autopsies, our results may not be representative of 
the general population. No clinical history was collected 
to correlate with imaging and histological findings. Also, 
our results may not be consistent as 4 coronary arteries 
were imaged with a clinical PET/CT, and 14 coronary 
arteries were imaged with a micro-PET/CT. However, a 
prior study by Irkle et al4 has found that 18F-NaF PET/
CT imaging of carotid arteries and correlative histological 
findings of calcification did not differ between a clinical 
PET and micro PET. 18F-NaF PET activity was not spe-
cific for the detection of intimal calcification. One of the 
plaque demonstrated both intimal calcification as well as 
calcification of the internal elastic lamina, which corre-
lated to 18F-NaF PET activity. The study was also limited 
by small sample size, likely under powering the evaluation 
of the relationship between inflammation and calcifica-
tion. Finally, quantitative analysis in addition to our quali-
tative analysis of the area of calcification and 18F-NaF 
PET activity would have provided significant information.
Future Directions
Molecular imaging of the coronary arteries with 18F-NaF 
PET/CT is a promising imaging modality for the detection 
of high-risk plaque.21 18F-NaF activity has been shown to 
correlate with vulnerable plaque features including micro-
calcification, advanced plaque morphology, and inflam-
mation. More specifically, 18F-NaF PET/CT may be most 
useful in the detection of high-risk plaque and improved 
risk-stratification of individuals beyond what is currently 
available. Moving forward, 18F-NaF PET/CT could be eval-
uated in the clinical setting, with imaging of in vivo coronary 
arteries and correlating imaging findings with clinical out-
comes. Also, as the localization of the microcalcification of 
at least 5 µm to the fibrous cap has been found to be sig-
nificant in predicting plaque rupture,22,23 it will be interesting 
to evaluate this in detail. The localization of microcalcifica-
tion and 18F-NaF PET activity in relation to CD68 staining, 
and the quantitative evaluation of the area of microcalci-
fication, inflammation, fibrosis with 18F-NaF PET activity 
would also be important to evaluate in subsequent studies. 
18F-NaF PET/CT imaging has the potential to improve pre-
dictive models and may lead to significant reductions in the 
incidence of adverse events by streamlining of preventative 
therapies to the highest risk individuals.
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